However, dysregulation of cyclin D1 is frequently observed in human cancers, with gene amplification and overexpression documented in approximately 50% of breast and esophageal cancers (Barnes and Gillett 1998; Shamma et al. 2000). Here, CCND1 is linked to cancer.